<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jcp29785-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Potential antiviral therapeutics for experimental treatment of COVID‐19</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000" valign="bottom">
    <th valign="bottom" rowspan="1" colspan="1">Drug</th>
    <th valign="bottom" rowspan="1" colspan="1">Activity</th>
    <th valign="bottom" rowspan="1" colspan="1">Effectiveness</th>
    <th valign="bottom" rowspan="1" colspan="1">The drug's mechanism of action in COVID‐19</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td valign="top" rowspan="1" colspan="1">Kaletra (lopinavir/ritonavir)</td>
    <td valign="top" rowspan="1" colspan="1">Used to treat HIV infection</td>
    <td valign="top" rowspan="1" colspan="1">400 mg/100 mg twice daily</td>
    <td valign="top" rowspan="1" colspan="1">Protease inhibitor</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">Chloroquine</td>
    <td valign="top" rowspan="1" colspan="1">Inhibit quinone reductase 2 that used to treat malaria infection</td>
    <td valign="top" rowspan="1" colspan="1">200 mg, three times per day during 10 days</td>
    <td valign="top" rowspan="1" colspan="1">Block virus infection by increasing endosomal pH required for virus/cell fusion, interfering with the glycosylation of cellular receptors of SARS‐CoV</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">Remdesivir (GS‐5734)</td>
    <td valign="top" rowspan="1" colspan="1">An adenosine nucleotide analog inhibitor of RdRp</td>
    <td valign="top" rowspan="1" colspan="1">10 mg/kg for 12 days</td>
    <td valign="top" rowspan="1" colspan="1">A novel nucleotide analogs against single‐stranded RNA viruses such as coronaviruses</td>
   </tr>
   <tr>
    <td rowspan="2" valign="top" colspan="1">IFN‐ alpha</td>
    <td rowspan="2" valign="top" colspan="1">Used to treat HBV infection</td>
    <td valign="top" rowspan="1" colspan="1">5 million U bid inhalation</td>
    <td rowspan="2" valign="top" colspan="1">A broad‐spectrum antiviral drug</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">5 million U or equivalent dose each time, two times/day</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">Umifenovir (Arbidol)</td>
    <td valign="top" rowspan="1" colspan="1">Used to treat influenza virus infection</td>
    <td valign="top" rowspan="1" colspan="1">200 mg each time, three times/day</td>
    <td valign="top" rowspan="1" colspan="1">Inhibit viral entry into target cells and stimulate the immune response</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">Oseltamivir (Tamiflu)</td>
    <td valign="top" rowspan="1" colspan="1">Used to treat influenza virus infection</td>
    <td valign="top" rowspan="1" colspan="1">75 mg every 12 hr</td>
    <td valign="top" rowspan="1" colspan="1">Neuraminidase inhibitors</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">Ribavirin</td>
    <td valign="top" rowspan="1" colspan="1">Used to treat RSV infection, hepatitis C, and some viral hemorrhagic fevers</td>
    <td valign="top" rowspan="1" colspan="1">500 mg each time, 2–3 times/day in combination with IFN‐α or lopinavir/ritonavir</td>
    <td valign="top" rowspan="1" colspan="1">A synthetic guanosine nucleoside that interferes with the synthesis of viral mRNA</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">Teicoplanin</td>
    <td valign="top" rowspan="1" colspan="1">A glycopeptide antibiotic that used to treat Gram‐positive bacterial infection</td>
    <td valign="top" rowspan="1" colspan="1">To inhibit 50% of viruses (IC50) in vitro was 1.66 μM</td>
    <td valign="top" rowspan="1" colspan="1">Inhibiting the low pH cleavage of the viral spike protein and the continuation of virus replication cycle</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">Favipiravir (FPV)</td>
    <td valign="top" rowspan="1" colspan="1">Used to treat many RNA viruses infections</td>
    <td valign="top" rowspan="1" colspan="1">600 mg twice daily</td>
    <td valign="top" rowspan="1" colspan="1">Inhibition of viral RdRp</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="jcp29785-tbl1-note-0001">
   <p>Abbreviations: COVID‐19, coronavirus disease‐19; HBV, hepatitis B virus; IFN‐α interferon‐α; mRNA, messenger RNA; RdRp, RNA‐dependent RNA polymerase; RSV, respiratory syncytial virus; SARS‐CoV, severe acute respiratory syndrome‐related coronavirus.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
  <license>
   <license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
  </license>
 </permissions>
</table-wrap>
